• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在肌萎缩侧索硬化症的小鼠模型中存在一个普遍的共同终点。

One universal common endpoint in mouse models of amyotrophic lateral sclerosis.

机构信息

School of Kinesiology and Health Science, Faculty of Health, York University, Toronto, Ontario, Canada.

出版信息

PLoS One. 2011;6(6):e20582. doi: 10.1371/journal.pone.0020582. Epub 2011 Jun 8.

DOI:10.1371/journal.pone.0020582
PMID:21687686
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3110799/
Abstract

There is no consensus among research laboratories around the world on the criteria that define endpoint in studies involving rodent models of amyotrophic lateral sclerosis (ALS). Data from 4 nutrition intervention studies using 162 G93A mice, a model of ALS, were analyzed to determine if differences exist between the following endpoint criteria: CS 4 (functional paralysis of both hindlimbs), CS 4+ (CS 4 in addition to the earliest age of body weight loss, body condition deterioration or righting reflex), and CS 5 (CS 4 plus righting reflex >20 s). The age (d; mean ± SD) at which mice reached endpoint was recorded as the unit of measurement. Mice reached CS 4 at 123.9±10.3 d, CS 4+ at 126.6±9.8 d and CS 5 at 127.6±9.8 d, all significantly different from each other (P<0.001). There was a significant positive correlation between CS 4 and CS 5 (r = 0.95, P<0.001), CS 4 and CS 4+ (r = 0.96, P<0.001), and CS 4+ and CS 5 (r = 0.98, P<0.001), with the Bland-Altman plot showing an acceptable bias between all endpoints. Logrank tests showed that mice reached CS 4 24% and 34% faster than CS 4+ (P = 0.046) and CS 5 (P = 0.006), respectively. Adopting CS 4 as endpoint would spare a mouse an average of 4 days (P<0.001) from further neuromuscular disability and poor quality of life compared to CS 5. Alternatively, CS 5 provides information regarding proprioception and severe motor neuron death, both could be important parameters in establishing the efficacy of specific treatments. Converging ethics and discovery, would adopting CS 4 as endpoint compromise the acquisition of insight about the effects of interventions in animal models of ALS?

摘要

目前,在使用 G93A 转基因鼠(ALS 的一种模型)进行的营养干预研究中,全世界的研究实验室尚未就终点标准达成共识。本研究分析了 4 项营养干预研究的数据,这些研究共涉及 162 只 G93A 转基因鼠,旨在确定以下终点标准之间是否存在差异:CS 4(双侧后肢功能瘫痪)、CS 4+(CS 4 外加最早的体重减轻、身体状况恶化或翻正反射消失的年龄)和 CS 5(CS 4 外加翻正反射>20 s)。记录小鼠达到终点的年龄(d;平均值±标准差)作为测量单位。小鼠达到 CS 4 的时间为 123.9±10.3 d,达到 CS 4+的时间为 126.6±9.8 d,达到 CS 5 的时间为 127.6±9.8 d,所有这些时间均显著不同(P<0.001)。CS 4 与 CS 5(r=0.95,P<0.001)、CS 4 与 CS 4+(r=0.96,P<0.001)以及 CS 4+与 CS 5(r=0.98,P<0.001)之间存在显著的正相关关系,Bland-Altman 图显示所有终点之间的偏差可接受。对数秩检验显示,与 CS 4+(P=0.046)和 CS 5(P=0.006)相比,CS 4 分别使小鼠提前 24%和 34%达到终点。与 CS 5 相比,采用 CS 4 作为终点可使小鼠平均提前 4 天(P<0.001)免受进一步的神经肌肉功能障碍和生活质量下降的影响。相反,CS 5 提供了关于本体感觉和严重运动神经元死亡的信息,这两者都可能是评估特定治疗效果的重要参数。从伦理和发现的角度来看,如果采用 CS 4 作为终点,是否会影响对 ALS 动物模型中干预效果的深入了解?

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ddb/3110799/5b53f732746c/pone.0020582.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ddb/3110799/e8b4155bf7ee/pone.0020582.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ddb/3110799/812f791ee662/pone.0020582.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ddb/3110799/1638f81b0a49/pone.0020582.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ddb/3110799/5b53f732746c/pone.0020582.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ddb/3110799/e8b4155bf7ee/pone.0020582.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ddb/3110799/812f791ee662/pone.0020582.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ddb/3110799/1638f81b0a49/pone.0020582.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ddb/3110799/5b53f732746c/pone.0020582.g004.jpg

相似文献

1
One universal common endpoint in mouse models of amyotrophic lateral sclerosis.在肌萎缩侧索硬化症的小鼠模型中存在一个普遍的共同终点。
PLoS One. 2011;6(6):e20582. doi: 10.1371/journal.pone.0020582. Epub 2011 Jun 8.
2
Novel behavioural characteristics of the superoxide dismutase 1 G93A (SOD1 ) mouse model of amyotrophic lateral sclerosis include sex-dependent phenotypes.肌萎缩侧索硬化症 SOD1 G93A (超氧化物歧化酶 1 )转基因小鼠模型的新型行为特征包括性别依赖性表型。
Genes Brain Behav. 2020 Feb;19(2):e12604. doi: 10.1111/gbb.12604. Epub 2019 Sep 10.
3
Motor neuron dysfunction in a mouse model of ALS: gender-dependent effect of P2X7 antagonism.肌萎缩侧索硬化症小鼠模型中的运动神经元功能障碍:P2X7 拮抗剂的性别依赖性作用。
Toxicology. 2013 Sep 6;311(1-2):69-77. doi: 10.1016/j.tox.2013.04.004. Epub 2013 Apr 11.
4
Vitamin D3 deficiency differentially affects functional and disease outcomes in the G93A mouse model of amyotrophic lateral sclerosis.维生素 D3 缺乏症在肌萎缩侧索硬化症 G93A 小鼠模型中对功能和疾病结果的影响不同。
PLoS One. 2011;6(12):e29354. doi: 10.1371/journal.pone.0029354. Epub 2011 Dec 27.
5
Optimizing the Translational Value of Mouse Models of ALS for Dysphagia Therapeutic Discovery.优化肌萎缩侧索硬化症(ALS)小鼠模型的转化价值,以促进吞咽障碍治疗的发现。
Dysphagia. 2020 Apr;35(2):343-359. doi: 10.1007/s00455-019-10034-9. Epub 2019 Jul 12.
6
Pre-symptomatic detection of chronic motor deficits and genotype prediction in congenic B6.SOD1(G93A) ALS mouse model.在 B6.SOD1(G93A) ALS 同种系小鼠模型中进行慢性运动缺陷的症状前检测和基因型预测。
Neuroscience. 2009 Dec 15;164(3):975-85. doi: 10.1016/j.neuroscience.2009.08.031. Epub 2009 Aug 20.
7
Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex.运动皮层中突变型 SOD1 的抑制可使 SOD1G93A 肌萎缩侧索硬化症大鼠模型的发病延迟和生存时间延长。
J Neurosci. 2014 Nov 19;34(47):15587-600. doi: 10.1523/JNEUROSCI.2037-14.2014.
8
Absence of toll-like receptor 4 (TLR4) extends survival in the hSOD1 G93A mouse model of amyotrophic lateral sclerosis.在肌萎缩侧索硬化症的人超氧化物歧化酶1 G93A小鼠模型中,Toll样受体4(TLR4)的缺失可延长生存期。
J Neuroinflammation. 2015 May 13;12:90. doi: 10.1186/s12974-015-0310-z.
9
Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.胍那苄可延缓疾病症状的出现,延长寿命,改善运动能力,并减轻肌萎缩侧索硬化症SOD1 G93A小鼠模型中的运动神经元损失。
Neuroscience. 2014 Sep 26;277:132-8. doi: 10.1016/j.neuroscience.2014.03.047. Epub 2014 Mar 31.
10
A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS.一种用于评估肌萎缩侧索硬化症SOD1-G93A小鼠模型疾病进展的快速表型神经评分系统。
J Vis Exp. 2015 Oct 6(104):53257. doi: 10.3791/53257.

引用本文的文献

1
Mitigation of TDP-43 toxic phenotype by an RGNEF fragment in amyotrophic lateral sclerosis models.肌萎缩侧索硬化症模型中 RGNEF 片段对 TDP-43 毒性表型的缓解作用。
Brain. 2024 Jun 3;147(6):2053-2068. doi: 10.1093/brain/awae078.
2
Assessing the therapeutic impact of resveratrol in ALS SOD1-G93A mice with electrical impedance myography.用电阻抗肌电图评估白藜芦醇对肌萎缩侧索硬化症SOD1-G93A小鼠的治疗效果。
Front Neurol. 2022 Dec 22;13:1059743. doi: 10.3389/fneur.2022.1059743. eCollection 2022.
3
Methodological standards, quality of reporting and regulatory compliance in animal research on amyotrophic lateral sclerosis: a systematic review.

本文引用的文献

1
Uridine ameliorates the pathological phenotype in transgenic G93A-ALS mice.尿苷可改善转基因G93A-ALS小鼠的病理表型。
Amyotroph Lateral Scler. 2010 Dec;11(6):520-30. doi: 10.3109/17482968.2010.491867. Epub 2010 Jun 22.
2
Intracerebroventricular infusion of monoclonal antibody or its derived Fab fragment against misfolded forms of SOD1 mutant delays mortality in a mouse model of ALS.鞘内注射针对 SOD1 突变体错误折叠形式的单克隆抗体或其衍生 Fab 片段可延迟 ALS 小鼠模型的死亡率。
J Neurochem. 2010 Jun;113(5):1188-99. doi: 10.1111/j.1471-4159.2010.06683.x. Epub 2010 Mar 14.
3
Caloric restriction shortens lifespan through an increase in lipid peroxidation, inflammation and apoptosis in the G93A mouse, an animal model of ALS.
肌萎缩侧索硬化症动物研究中的方法学标准、报告质量及法规遵循情况:一项系统综述
BMJ Open Sci. 2019 Aug 1;3(1):e000016. doi: 10.1136/bmjos-2018-000016. eCollection 2019.
4
Locomotor deficits in a mouse model of ALS are paralleled by loss of V1-interneuron connections onto fast motor neurons.肌萎缩侧索硬化症(ALS)小鼠模型的运动缺陷与 V1 中间神经元与快肌运动神经元连接的丧失相平行。
Nat Commun. 2021 May 31;12(1):3251. doi: 10.1038/s41467-021-23224-7.
5
Blocking glutamate mGlu receptors with the negative allosteric modulator CTEP improves disease course in SOD1 mouse model of amyotrophic lateral sclerosis.负变构调节剂 CTEP 阻断谷氨酸 mGlu 受体可改善肌萎缩侧索硬化症 SOD1 小鼠模型的疾病进程。
Br J Pharmacol. 2021 Sep;178(18):3747-3764. doi: 10.1111/bph.15515. Epub 2021 Jun 29.
6
The role of the IACUC in ensuring research reproducibility.IACUC 在确保研究可重复性方面的作用。
Lab Anim (NY). 2017 Mar 22;46(4):129-135. doi: 10.1038/laban.1213.
7
Imaging of brain TSPO expression in a mouse model of amyotrophic lateral sclerosis with (18)F-DPA-714 and micro-PET/CT.使用(18)F-DPA-714和微型PET/CT对肌萎缩侧索硬化小鼠模型中的脑TSPO表达进行成像。
Eur J Nucl Med Mol Imaging. 2016 Jul;43(7):1348-59. doi: 10.1007/s00259-016-3311-y. Epub 2016 Jan 27.
8
Dietary Vitamin D3 Restriction Exacerbates Disease Pathophysiology in the Spinal Cord of the G93A Mouse Model of Amyotrophic Lateral Sclerosis.饮食中维生素D3限制加剧肌萎缩侧索硬化症G93A小鼠模型脊髓中的疾病病理生理过程。
PLoS One. 2015 May 28;10(5):e0126355. doi: 10.1371/journal.pone.0126355. eCollection 2015.
9
Neuron-specific antioxidant OXR1 extends survival of a mouse model of amyotrophic lateral sclerosis.神经元特异性抗氧化剂OXR1可延长肌萎缩侧索硬化症小鼠模型的生存期。
Brain. 2015 May;138(Pt 5):1167-81. doi: 10.1093/brain/awv039. Epub 2015 Mar 9.
10
Elevated mRNA-levels of distinct mitochondrial and plasma membrane Ca(2+) transporters in individual hypoglossal motor neurons of endstage SOD1 transgenic mice.在终末期 SOD1 转基因小鼠的单个舌下运动神经元中,存在不同的线粒体和质膜 Ca(2+)转运体的 mRNA 水平升高。
Front Cell Neurosci. 2014 Nov 14;8:353. doi: 10.3389/fncel.2014.00353. eCollection 2014.
热量限制通过增加 G93A 小鼠(ALS 的动物模型)中的脂质过氧化、炎症和细胞凋亡来缩短寿命。
PLoS One. 2010 Feb 24;5(2):e9386. doi: 10.1371/journal.pone.0009386.
4
Methionine sulfoximine, an inhibitor of glutamine synthetase, lowers brain glutamine and glutamate in a mouse model of ALS.亚精胺,谷氨酰胺合成酶抑制剂,降低 ALS 小鼠模型中的脑谷氨酸盐和谷氨酸盐。
J Neurol Sci. 2010 Mar 15;290(1-2):41-7. doi: 10.1016/j.jns.2009.11.013. Epub 2010 Jan 8.
5
Multiple system degeneration with basophilic inclusions in Japanese ALS patients with FUS mutation.日本肌萎缩侧索硬化症伴 FUS 突变患者的多系统退化伴嗜碱性包涵体。
Acta Neuropathol. 2010 Mar;119(3):355-64. doi: 10.1007/s00401-009-0621-1. Epub 2009 Dec 5.
6
Lead exposure stimulates VEGF expression in the spinal cord and extends survival in a mouse model of ALS.铅暴露刺激脊髓中 VEGF 的表达,并延长 ALS 小鼠模型的存活时间。
Neurobiol Dis. 2010 Mar;37(3):574-80. doi: 10.1016/j.nbd.2009.11.007. Epub 2009 Nov 13.
7
Effect of rosmarinic acid in motor dysfunction and life span in a mouse model of familial amyotrophic lateral sclerosis.迷迭香酸对家族性肌萎缩侧索硬化症小鼠模型运动功能障碍和寿命的影响。
J Neurosci Res. 2010 Mar;88(4):896-904. doi: 10.1002/jnr.22242.
8
Dietary supplementation with S-adenosyl methionine delays the onset of motor neuron pathology in a murine model of amyotrophic lateral sclerosis.补充 S-腺苷甲硫氨酸可延缓肌萎缩侧索硬化症小鼠模型中运动神经元病理的发生。
Neuromolecular Med. 2010 Mar;12(1):86-97. doi: 10.1007/s12017-009-8089-7. Epub 2009 Sep 16.
9
Lenalidomide (Revlimid) administration at symptom onset is neuroprotective in a mouse model of amyotrophic lateral sclerosis.在肌萎缩侧索硬化症小鼠模型中,在症状出现时给予来那度胺(瑞复美)具有神经保护作用。
Exp Neurol. 2009 Nov;220(1):191-7. doi: 10.1016/j.expneurol.2009.08.028. Epub 2009 Sep 4.
10
Intra-bone marrow-bone marrow transplantation slows disease progression and prolongs survival in G93A mutant SOD1 transgenic mice, an animal model mouse for amyotrophic lateral sclerosis.骨髓内骨髓移植可减缓疾病进展并延长G93A突变型超氧化物歧化酶1转基因小鼠(一种肌萎缩侧索硬化症的动物模型小鼠)的生存期。
Brain Res. 2009 Nov 3;1296:216-24. doi: 10.1016/j.brainres.2009.08.012. Epub 2009 Aug 15.